Therwil, Switzerland

Lászlo Révész

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 1.9

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1998-2010

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations of Laszlo Revesz: Breakthroughs in Pharmaceutical Patents

Introduction: Laszlo Revesz is an accomplished inventor based in Therwil, Switzerland, with a notable emphasis on pharmaceutical innovations. With three patents to his name, Revesz is making significant contributions to the field of medicine through his research and development in therapeutic compounds.

Latest Patents: Among his recent patents, the most distinguished include the invention of tetracyclic lactame derivatives. This invention describes tetracyclic compounds of formula (IA) or (IB), which are crucial in treating diseases influenced by MK-2 or TNF activity. The patent also outlines methods for manufacturing these compounds. Another significant patent focuses on pyridine derivatives, detailing a process for producing pyridinoline and deoxypyridinoline crosslinks and deriving their applications in diagnosing connective tissue disorders in both humans and animals.

Career Highlights: Laszlo Revesz has made remarkable strides in his career while working at Novartis AG. His expertise in developing pharmaceutical compounds has earned him recognition in the industry, reflecting his commitment to improving healthcare solutions.

Collaborations: Throughout his inventive journey, Revesz has collaborated with talented coworkers, including Achim Schlapbach and Guido Koch. Their collective efforts have facilitated advancements in drug development and contributed to the innovative research conducted at Novartis AG.

Conclusion: Laszlo Revesz's dedication to research and invention in the pharmaceutical sector showcases his potential to impact medical science positively. With a solid portfolio of patents and a collaborative spirit, he continues to push the boundaries of innovation, paving the way for future therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…